AtG Therapeutics
PrivateLast Round
Grant
Mar 1, 2024
Total Funding Raised
$2.05M
Company Overview
AtG Therapeutics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Grant round in March 2024.
AtG Therapeutics is a biotechnology company that develops small molecule drug candidates and biomarkers to prevent tumor adaptation and resistance in cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AtG Therapeutics Comparables
Compare AtG Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessellate BIO | 86% | |
| Iteria Biopharma | 83% | |
| Medibiofarma | 80% |
For institutional investors. Book with your work email.
AtG Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2024 | ||||
| Seed | Jul 21, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AtG Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Women Angels for STEAM | Seed |
| Inveniam Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 2588% MoM, from 113 to 3K.
- Feb 21, 2026
Grew 50% QoQ, from 6 to 9 employees.
For institutional investors. Book with your work email.
AtG Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AtG Therapeutics's valuation, stock price, and market status.
Is AtG Therapeutics a public or private company?
AtG Therapeutics is a private company.
What is the current stock price of AtG Therapeutics?
AtG Therapeutics is a private company, so its shares have no public market price. Caplight tracks AtG Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AtG Therapeutics worth (valuation)?
Valuation information for AtG Therapeutics is not publicly available.
Can I buy AtG Therapeutics stock?
AtG Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AtG Therapeutics's last funding round?
AtG Therapeutics's most recent funding round was Grant on March 1, 2024.
Who are the main investors in AtG Therapeutics?
Key investors in AtG Therapeutics include Eurostars SME programme, Women Angels for STEAM, Inveniam Group.
Will AtG Therapeutics IPO soon?
No public IPO plans have been announced for AtG Therapeutics.
How can I track AtG Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AtG Therapeutics's shares on secondary markets.